Data derived from PhenomiR
PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
18525125 |
Alzheimer disease, susceptibility to - 104300 |
Neurological |
cerebellum |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
18560586 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary |
miRNA downregulation |
- |
2.12766 |
- |
Patient study phenotype-control |
miRNA microarray
|
17606841 |
Cardiomyopathy, dilated - 115200 |
Cardiovascular |
left ventricle |
miRNA overexpression |
- |
2.13 |
- |
Patient study phenotype-control |
miRNA microarray
|
17606841 |
- |
- |
left ventricle |
miRNA downregulation |
- |
6.7 |
- |
Bioprocess study |
miRNA microarray
|
17942673 |
Duchenne muscular dystrophy - 310200 |
Muscular |
muscle |
miRNA overexpression |
- |
7.63 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2A - 253600 |
Muscular |
muscle |
miRNA overexpression |
- |
3.41 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2B - 253601 |
Muscular |
muscle |
miRNA overexpression |
- |
6.2 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Miyoshi myopathy - 254130 |
Muscular |
muscle |
miRNA overexpression |
- |
2.28 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Myopathy, nemaline, 3 - 161800 |
Muscular |
muscle |
miRNA overexpression |
- |
23.24 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (Dermatomyositis - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
3.37 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (Inclusion body myopathy - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
3.3 |
- |
Patient study phenotype-control |
miRNA microarray
|
18973228 |
Medulloblastoma - 155255 |
Cancer |
cerebellum |
miRNA downregulation |
- |
20.0 |
- |
Patient study phenotype-control |
quantitative PCR
|
17622355 |
Psoriasis, susceptibility to - 177900 |
Dermatological |
skin |
miRNA downregulation |
- |
1.40845 |
- |
Patient study phenotype-control |
miRNA microarray
|
16192569 |
Breast cancer - 114480 |
Cancer |
T-47D cell |
miRNA downregulation |
- |
20.0 |
- |
Cell culture study |
quantitative PCR
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.83352 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.20511 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.26855 |
- |
Patient study phenotype-control |
miRNA microarray
|
16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
18563458 |
Autism, susceptibility to - 209850 |
Psychiatric |
cerebellar cortex |
miRNA downregulation |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
16754881 |
Breast cancer - 114480 |
Cancer |
breast epithelium |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA downregulation |
- |
- |
- |
Cell culture study |
array CGH
|
16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA downregulation |
- |
6.66667 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
Tsu-Pr1 cell |
miRNA downregulation |
- |
33.3333 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA downregulation |
- |
3.0303 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA downregulation |
- |
16.6667 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA downregulation |
- |
5.88235 |
- |
Cell culture study |
quantitative PCR
|
18647411 |
- |
- |
hematopoietic stem cell |
miRNA downregulation |
- |
4.61 |
- |
Bioprocess study |
miRNA microarray
|
16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|